Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Chen, C. S.
	Articles by Jensen, P. J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Chen, C. S.
	Articles by Jensen, P. J.

Ando, Y. and Jensen, P. J (1993). Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J. Invest. Dermatol 100, 633-639.[Medline]

Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A. and Stacey, S. N (1990). Plasminogen activator inhibitors: hormonally regulated serpins. Mol. Cell. Endocrinol 68, 1-19.[Medline]

Asselineau, D., Bernard, B. A., Bailly, C., Darmon, M., and Prunieras, M. D (1986). Human epidermis reconstructed by culture: is it \322normal\323?. J. Invest. Dermatol 86, 181-186.[Medline]

Asselineau, D., Bernard, B. A., Bailly, C., and Darmon, M (1989). Retinoic acid improves epidermal morphogenesis. Dev. Biol 133, 322-335.[Medline]

Asselineau, D. and Prunieras, M (1984). Reconstruction of \324simplified' skin: control of fabrication. Brit. J. Dermatol 111, 27-.

Astedt, B., Lecander, I., Brodin, T., Lundblad, A., and Low, K (1985). Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb. Haemost 53, 122-125.[Medline]

Baird, J., Lazarus, G. S., Belin, D., Vasselli, J. D., Busso, N., Gubler, P., and Jensen, P. J (1990). mRNA for tissue type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal skin. J. Invest. Dermatol 95, 458-552.

Bell, E., Sher, S., Hull, B., Merrill, C., Rosen, S., Chamson, A., Asselineau, D., Dubertret, L., Coulomb, B., Lapiere, C., Nusgens, B., and Neveux, Y (1983). The reconstitution of living skin. J. Invest. Dermatol 81, 2-.[Medline]

Bernard, B. A., Asselineau, D., Schaffar-Deshayes, L., and Darmon, M. Y (1988). Abnormal sequence of expression of differentiation markers in psoriatic epidermis: Inversion of two steps in the differentiation program?. J. Invest. Dermatol 90, 801-805.[Medline]

Boyce, S. T. and Ham, R. G (1983). Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J. Invest. Dermatol 81, 33-.

Choi, Y. and Fuchs, E (1990). TGF-and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regulation 1, 791-809.[Medline]

Cotsarelis, G., Cheng, S. Z., Dong, G., Sun, T. T., and Lavker, R. M (1989). Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate; implications on epithelial stem cells. Cell 57, 201-209.[Medline]

Dan\277, K., Andreasen, P. A., Gr\277ndahl-Hansen, J., Kristensen, P., Nielsen, L. S. and Skriver, L (1985). Plasminogen activators, tissue degradation, and cancer. Advan. Can. Res 44, 139-266.[Medline]

Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Paques, E.-P., Preissner, K. T., Muller-Berghaus, G., and Collen, D (1988). Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. J. Biol. Chem 263, 15454-15463.[Abstract/Free Full Text]

Erickson, L. A., Hekman, C. M., and Loskutoff, D. J (1985). The primary plasminogen activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc. Nat. Acad. Sci. USA 82, 8710-8714.[Abstract/Free Full Text]

Fay, W. P., Shapiro, A. D., Shih, J. L., Schleef, R. R., and Ginsburg, D (1992). Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. New Eng. J. Med 327, 1729-1733.[Medline]

Fisher, R., Waller, E. K., Grossi, G., Thompson, D., Tizard, R., and Schleuning, W (1985). Isolation and characterization of the human tissue type plasminogen activator gene including its 5flanking region. J. Biol. Chem 260, 11223-11230.[Abstract/Free Full Text]

Fuchs, E (1990). Epidermal differentiation: the bare essentials. J. Cell Biol 111, 2807-2814.[Free Full Text]

Gr\277ndahl-Hansen, J., Lund, L. R., Ralfkiaer, E., Ottevanger, V., and Dan\277, K (1988). Urokinase-and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J. Invest. Dermatol 90, 790-795.[Medline]

Gr\277ndahl-Hansen, J., Ralfkiaer, E., Nielsen, L. S., Kristensen, P., Frentz, G., and Dan\277, K (1987). Immunohistochemical localization of urokinase-and tissue-type plasminogen activators in psoriatic skin. J. Invest. Dermatol 88, 28-32.[Medline]

Hibino, T., Izaki, S., Ohkuma, M., Kon, S., Thorsen, S., and Astedt, B (1988). Epidermal plasminogen activator inhibitor (PAI) is immunologically identical to placental-type PAI-2. FEBS Lett 231, 202-206.[Medline]

Isseroff, R. R. and Rifkin, D. B (1983). Plasminogen is present in the basal layer of epidermis. J. Invest. Dermatol 80, 297-299.[Medline]

Jensen, P. J., Baird, J., Morioka, S., Lessin, S., and Lazarus, G. S (1988). Epidermal plasminogen activator is abnormal in cutaneous lesions. J. Invest. Dermatol 90, 777-782.[Medline]

Jensen, P. J. and Wheelock, M. J (1992). Regulation of urokinase plasminogen activator localization in keratinocytes by calcium ion and E-cadherin. Exp. Cell Res 202, 190-198.[Medline]

Joslin, G., Griffin, G. l., August, A. M., Adams, S., Fallon, R. J., Senior, R. M., and Perlmutter, D. H (1992). The serpin-enzyme complex receptor mediates the neutrophil chemotactic effect of alpha-1-antitrypsin-elastase complexes and amyloid-peptide. J. Clin. Invest 90, 1150-1154.

Kilpatrick, L., Johnson, J. L., Nickbarg, E. B., Wang, Z. M., Clifford, T. F., Banach, M., Cooperman, B. S., Douglas, S. D., and Rubin, H (1991). Inhibition of human neutrophil superoxide generation by alpha-1 antichymotrypsin. J. Immunol 146, 2388-2393.[Abstract]

Kirchheimer, J. C., Wojta, J., Christ, G., and Binder, B. R (1987). Proliferation of a human epidermal tumor cell line stimulated by urokinase. FASEB J 1, 125-128.[Abstract]

Kirchheimer, J. C., Wojta, J., Hienert, G., Christ, G., Heger, M. E., Pfluger, H., and Binder, B. R (1987). Effect of urokinase on the proliferation of primary cultures of human prostatic cells. Thromb. Res 48, 291-298.[Medline]

Kopan, R. and Fuchs, E (1989). The use of retinoic acid to probe the relation between hyperproliferation-associated keratins and cell proliferation in normal and malignant epidermal cells. J. Cell Biol 109, 295-307.[Abstract/Free Full Text]

Kopan, R., Grazina, T., and Fuchs, E (1987). Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J. Cell Biol 105, 427-440.[Abstract/Free Full Text]

Kruithof, E. K. O., Vassalli, J.-D., Schleuning, W.-D., Mattaliano, R. J., and Bachman, F (1986). Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell U937. J. Biol. Chem 261, 11207-11213.[Abstract/Free Full Text]

Loskutoff, D. J (1988). Type 1 plasminogen activator inhibitor and its potential influence on thrombolytic therapy. Seminars in Thrombosis and Hemostasis 14, 100-109.[Medline]

Loskutoff, D. J., van Mourik, J. A., Erickson, L. A. and Lawrence, D (1983). Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc. Nat. Acad. Sci. USA 80, 2956-2960.[Abstract/Free Full Text]

Mansbridge, J. N. and Knapp, A. M (1987). Changes in keratinocyte maturation during wound healing. J. Invest. Dermatol 89, 253-263.[Medline]

Miller, S. J., Jensen, P. J., Dzubow, L. M., and Lazarus, G. S (1992). Urokinase plasminogen activator is immunocytochemically detectableinsquamous cell but not basal cell carcinomas. J. Invest. Dermatol 98, 351-358.[Medline]

Morioka, S., Jensen, P. J., and Lazarus, G. S (1985). Human epidermal plasminogen activator, characterization, localization, and modulation. Exp. Cell Res 161, 364-372.[Medline]

Murphy, G. F., Flynn, T. C., Rice, R. H., and Pinkus, G. S (1984). Involucrin expression in normal and neoplastic human skin: a marker for keratinocyte differentiation. J. Invest. Dermatol 82, 453-457.[Medline]

Pollanen, J., Stephens, R. W., and Vaheri, A (1991). Directed plasminogen activation at the surface of normal and malignant cells. Advan. Can. Res 57, 273-328.[Medline]

Rabbani, S. A., Desjardins, J., Bell, A. W., Banville, D., Mazar, A., Henkin, J., and Goltzman, D (1990). An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem. Biophys. Res. Commun 173, 1058-1064.[Medline]

Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J., and Goltzman, D (1992). Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem 267, 14151-14156.[Abstract/Free Full Text]

Rijken, D. C., Hoylaerts, M., and Collen, D (1982). Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J. Biol. Chem 257, 2920-2925.[Free Full Text]

R\277mer, J., Lund, L. R., Eriksen, J., Ralfkiaer, E., Zeheb, R., Gelehrter, T. D., and Dano, K (1991). Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J. Invest. Dermatol 97, 803-811.[Medline]

Schleuning, W.-D., Medcalf, R. L., Hession, C., Rothenbuhler, R., Shaw, A., and Kruithof, E. K. O (1987). Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol. Cell. Biol 7, 4564-4567.[Abstract/Free Full Text]

Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B., and Loskutoff, D. J (1992). Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Nat. Acad. Sci. USA 89, 6998-7002.[Abstract/Free Full Text]

Schleef, R. R., Wagner, N. V., and Loskutoff, D. J (1988). Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells. J. Cell. Physiol 134, 269-274.[Medline]

Seiffert, D. and Loskutoff, D. J (1991). Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin. J. Biol. Chem 266, 2824-2830.[Abstract/Free Full Text]

Shipley, G. D. and Pittelkow M. R (1987). Control of growth and differentiation in vitro of human keratinocytes cultured in serum-free medium. Arch. Dermatol 123, 1541-.

Thacher, S. M (1989). Purification of keratinocyte transglutaminase and its expression during squamous differentiation. J. Invest. Dermatol 89, 578-584.

Vassalli, J.-D., Sappino, A.-P., and Belin, D (1991). The plasminogen activator/plasmin system. J. Clin. Invest 88, 1067-1072.

Verde, P., Stopelli, M. P., Galleffi, M., DiNocera, P., and Blasi, F (1981). Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. Proc. Nat. Acad. Sci. USA 81, 4727-4731.

Wagner, O. F., De Vries, C., Hohmann, C., Veerman, H., and Pannekoek, H (1989). Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). J. Clin. Invest 84, 647-655.

Wun T.-C. and Reich, E (1987). An inhibitor of plasminogen activation from human placenta: purification and characterization. J. Biol. Chem 262, 3646-3653.[Abstract/Free Full Text]

This article has been cited by other articles:

G. D. Heda and L. K. Roberts
Role of Tissue-Type Plasminogen Activator in Salicylic Acid-Induced Sloughing of Human Corn Tissue
J Am Podiatr Med Assoc, September 1, 2008; 98(5): 345 - 352.
[Abstract] [Full Text] [PDF]

F. L. Scott, J. Sun, J. C. Whisstock, K. Kato, and P. I. Bird
SerpinB6 is an Inhibitor of Kallikrein-8 in Keratinocytes
J. Biochem., October 1, 2007; 142(4): 435 - 442.
[Abstract] [Full Text] [PDF]

K Kuwae, K Matsumoto-Miyai, S Yoshida, T Sadayama, K Yoshikawa, K Hosokawa, and S Shiosaka
Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples
Mol. Pathol., August 1, 2002; 55(4): 235 - 241.
[Abstract] [Full Text] [PDF]

M. M. Serewko, C. Popa, A. L. Dahler, L. Smith, G. M. Strutton, W. Coman, A. J. Dicker, and N. A. Saunders
Alterations in Gene Expression and Activity during Squamous Cell Carcinoma Development
Cancer Res., July 1, 2002; 62(13): 3759 - 3765.
[Abstract] [Full Text] [PDF]

F. Meier, M. Nesbit, M.-Y. Hsu, B. Martin, P. Van Belle, D. E. Elder, G. Schaumburg-Lever, C. Garbe, T. M. Walz, P. Donatien, et al.
Human Melanoma Progression in Skin Reconstructs : Biological Significance of bFGF
Am. J. Pathol., January 1, 2000; 156(1): 193 - 200.
[Abstract] [Full Text] [PDF]

D. L. Williams, B. Risse, S. Kim, D. Saunders, S. Orlin, M. S. Baker, P. J. Jensen, and R. M. Lavker
Plasminogen Activator Inhibitor Type 2 in Human Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1669 - 1675.
[Abstract] [Full Text] [PDF]

M.-Y. Hsu, D.-T. Shih, F. E. Meier, P. Van Belle, J.-Y. Hsu, D. E. Elder, C. A. Buck, and M. Herlyn
Adenoviral Gene Transfer of �3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma
Am. J. Pathol., November 1, 1998; 153(5): 1435 - 1442.
[Abstract] [Full Text] [PDF]

Z.-L. Chen, Y. Momota, K. Kato, M. Taniguchi, N. Inoue, S. Shiosaka, and S. Yoshida
Expression of Neuropsin mRNA in the Mouse Embryo and the Pregnant Uterus
J. Histochem. Cytochem., March 1, 1998; 46(3): 313 - 320.
[Abstract] [Full Text]

D. Yu, T Yang, T Sonoda, K Gaffney, P. Jensen, T Dooley, S Ledbetter, I. Freedberg, R Lavker, and T. Sun
Message of nexin 1, a serine protease inhibitor, is accumulated in the follicular papilla during anagen of the hair cycle
J. Cell Sci., January 12, 1995; 108(12): 3867 - 3874.
[Abstract] [PDF]

V. Ronfard and Y. Barrandon
Migration of keratinocytes through tunnels of digested fibrin
PNAS, April 10, 2001; 98(8): 4504 - 4509.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Chen, C. S.

Articles by Jensen, P. J.

Search for Related Content

PubMed

PubMed Citation

Articles by Chen, C. S.

Articles by Jensen, P. J.

				F. L. Scott, J. Sun, J. C. Whisstock, K. Kato, and P. I. Bird SerpinB6 is an Inhibitor of Kallikrein-8 in Keratinocytes J. Biochem., October 1, 2007; 142(4): 435 - 442. [Abstract] [Full Text] [PDF]

				K Kuwae, K Matsumoto-Miyai, S Yoshida, T Sadayama, K Yoshikawa, K Hosokawa, and S Shiosaka Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples Mol. Pathol., August 1, 2002; 55(4): 235 - 241. [Abstract] [Full Text] [PDF]

				M. M. Serewko, C. Popa, A. L. Dahler, L. Smith, G. M. Strutton, W. Coman, A. J. Dicker, and N. A. Saunders Alterations in Gene Expression and Activity during Squamous Cell Carcinoma Development Cancer Res., July 1, 2002; 62(13): 3759 - 3765. [Abstract] [Full Text] [PDF]

				F. Meier, M. Nesbit, M.-Y. Hsu, B. Martin, P. Van Belle, D. E. Elder, G. Schaumburg-Lever, C. Garbe, T. M. Walz, P. Donatien, et al. Human Melanoma Progression in Skin Reconstructs : Biological Significance of bFGF Am. J. Pathol., January 1, 2000; 156(1): 193 - 200. [Abstract] [Full Text] [PDF]

				D. L. Williams, B. Risse, S. Kim, D. Saunders, S. Orlin, M. S. Baker, P. J. Jensen, and R. M. Lavker Plasminogen Activator Inhibitor Type 2 in Human Corneal Epithelium Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1669 - 1675. [Abstract] [Full Text] [PDF]

				M.-Y. Hsu, D.-T. Shih, F. E. Meier, P. Van Belle, J.-Y. Hsu, D. E. Elder, C. A. Buck, and M. Herlyn Adenoviral Gene Transfer of �3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma Am. J. Pathol., November 1, 1998; 153(5): 1435 - 1442. [Abstract] [Full Text] [PDF]

				Z.-L. Chen, Y. Momota, K. Kato, M. Taniguchi, N. Inoue, S. Shiosaka, and S. Yoshida Expression of Neuropsin mRNA in the Mouse Embryo and the Pregnant Uterus J. Histochem. Cytochem., March 1, 1998; 46(3): 313 - 320. [Abstract] [Full Text]

				D. Yu, T Yang, T Sonoda, K Gaffney, P. Jensen, T Dooley, S Ledbetter, I. Freedberg, R Lavker, and T. Sun Message of nexin 1, a serine protease inhibitor, is accumulated in the follicular papilla during anagen of the hair cycle J. Cell Sci., January 12, 1995; 108(12): 3867 - 3874. [Abstract] [PDF]

				V. Ronfard and Y. Barrandon Migration of keratinocytes through tunnels of digested fibrin PNAS, April 10, 2001; 98(8): 4504 - 4509. [Abstract] [Full Text] [PDF]